Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
Bactericidal
Fluoroquinolone; topoisomerase IV and bacterial...
HEXIM1 activator.
Natriuretic, vasodilatory peptide fragment; B1/...
AMPK activator.
Neuroactive mycotoxin produced by Penicillum an...
AT1 inhibitor.
Phenol found in various plant sources, used to ...
Selective inhibitor of protein kinase C (PKC).<...
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
Synthetic ITC, erucin analog.
Diterpene found in Taxus; potential microtubule...
Diterpene found in coffee beans.
Mycotoxin produced by Aspergillus; actin polyme...
Tyrosine kinase inhibitor.
Synthetic isoflavone.
Peptide, substance P analog; NK agonist.
Tamoxifen derivative; potential proteasome inhi...
Endogenous calcitonin-family peptide frgament, ...
FGFR inhibitor.